Aging and chronic ailments like diabetes decrease the ability of the kidneys to recover from injuries, resulting in chronic kidney disease (CKD)
313 Several therapeutic approaches targeting Met metabolism, including Met restriction, MAT2A inhibitors IDE397 and AG-270, are in clinical trials, and their therapeutic effects need to be verified
We herein highlight some timely gaps and recommendations based on limited available evidence and expert opinion to help guide clinicians in addressing real-world questions raised in practice
Some patients benefit from staying at their current dose longer before advancing, while others respond better to a different medication in the GLP-1 class
- Tch cc gii c, tng cng sc khng bo v da khe mnh
It doesnt necessarily mean the medication has stopped working